# TMO — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-31. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 7 · Fundamentals 8.5 · Technicals 7 · Growth 8.5 · Risk 5.5

## Summary

Thermo Fisher Scientific (TMO) shows strong fundamentals with robust revenue growth and healthy margins, but technicals indicate near-term volatility amid a bullish forecast band. Recent earnings beat and analyst upgrades support upside potential, though valuation remains elevated relative to historical norms.

## Price targets (12-month horizon)

- Bear: $541.50
- Base: $620.00
- Bull: $650.00

## News context

Recent earnings beat and regulatory clearances have driven a 23.7% quarterly gain, with Piper Sandler raising PT to $600 and Morgan Stanley to $650. The company's broad-based momentum across key segments (Bioproduction, Clinical Research) supports growth potential. However, the high PEG ratio of 2.17 and elevated valuation (forward P/E 21.05) suggest caution on further upside.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/tmo-ai-stock-forecast-ca92c403a21dae0ae93218ffc70cf254
- AI-generated; model outputs can be wrong. Not financial advice.